Unnamed: 0,title,date,stock,sentiment
680486.0,85 Biggest Movers From Yesterday,2020-06-04 05:02:00-04:00,IRIX,neutral
680487.0,58 Stocks Moving In Wednesday's Mid-Day Session,2020-06-03 12:18:00-04:00,IRIX,neutral
680488.0,"Stifel Maintains Buy on Iridex, Lowers Price Target to $4",2020-05-12 09:29:00-04:00,IRIX,negative
680489.0,Iridex Withdraws Its FY20 Guidance,2020-05-11 16:26:00-04:00,IRIX,neutral
680490.0,"Iridex Q1 EPS $(0.120) Beats $(0.160) Estimate, Sales $9.000M Miss $9.760M Estimate",2020-05-11 16:25:00-04:00,IRIX,negative
680491.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-19 10:49:00-04:00,IRIX,negative
680492.0,"Iridex Q4 EPS $(0.11) Beats $(0.15) Estimate, Sales $11.8M Beat $10.88M Estimate",2020-03-12 16:31:00-04:00,IRIX,neutral
680493.0,94 Biggest Movers From Yesterday,2020-02-12 05:13:00-05:00,IRIX,neutral
680494.0,23 Medical Devices Stocks Moving In Thursday's Session,2020-01-23 12:58:00-05:00,IRIX,neutral
680495.0,27 Medical Devices Stocks Moving In Tuesday's Session,2020-01-21 14:36:00-05:00,IRIX,neutral
680496.0,80 Biggest Movers From Yesterday,2020-01-15 04:48:00-05:00,IRIX,neutral
680497.0,Mid-Afternoon Market Update: Dow Turns Lower; Stemline Therapeutics Shares Plummet,2020-01-14 14:15:00-05:00,IRIX,neutral
680498.0,Mid-Day Market Update: GameStop Falls Following Soft 2019 Holiday Sales; RTI Surgical Shares Climb,2020-01-14 12:26:00-05:00,IRIX,positive
680499.0,48 Stocks Moving In Tuesday's Mid-Day Session,2020-01-14 12:06:00-05:00,IRIX,neutral
680500.0,"IRIDEX Sees Prelim. Q4 Sales $11.6M-$11.8M vs $10.88M Est., Sees Prelim. FY19 Sales $43.3M-$43.5M vs $42.57M Est.",2020-01-13 16:06:00-05:00,IRIX,neutral
680501.0,66 Biggest Movers From Yesterday,2019-11-22 04:50:00-05:00,IRIX,neutral
680502.0,Iridex Reiterates FY19 Sales Guidance $41M-$44M Vs. $42.48M Est.,2019-11-07 17:37:00-05:00,IRIX,neutral
680503.0,"Iridex Q3 EPS $(0.13) Beats $(0.17) Estimate, Sales $10.664M Beat $10.08M Estimate",2019-11-07 17:36:00-05:00,IRIX,neutral
680504.0,IRIDEX Names Robert Gunst Chair; Ruediger Naumann-Etienee To Leave As Lead Independent Director,2019-10-28 16:18:00-04:00,IRIX,negative
680505.0,46 Biggest Movers From Yesterday,2019-09-24 04:02:00-04:00,IRIX,neutral
680506.0,Stocks That Hit 52-Week Lows On Monday,2019-09-23 13:35:00-04:00,IRIX,negative
680507.0,34 Stocks Moving In Monday's Mid-Day Session,2019-09-23 12:37:00-04:00,IRIX,neutral
680508.0,70 Biggest Movers From Yesterday,2019-09-17 05:11:00-04:00,IRIX,neutral
680509.0,48 Stocks Moving In Monday's Mid-Day Session,2019-09-16 12:32:00-04:00,IRIX,neutral
680510.0,Stocks That Hit 52-Week Lows On Friday,2019-09-13 15:08:00-04:00,IRIX,negative
680511.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,IRIX,negative
680512.0,"Iridex Q2 EPS $(0.18) Beats $(0.22) Estimate, Sales $10.4M Miss $10.94M Estimate",2019-08-06 16:31:00-04:00,IRIX,negative
680513.0,New 52-Week Lows For Monday Morning,2019-08-05 13:16:00-04:00,IRIX,negative
680514.0,Stocks That Set New 52-Week Lows Friday Morning,2019-08-02 10:46:00-04:00,IRIX,negative
680515.0,Stocks that Reached Yearly Lows Thursday Morning,2019-08-01 11:09:00-04:00,IRIX,negative
680516.0,"IRIDEX Names David Bruce Pres, CEO",2019-05-21 16:04:00-04:00,IRIX,neutral
680517.0,Iridex Sees FY19 Sales $43M-$46M vs $47.05M Est.,2019-03-05 16:09:00-05:00,IRIX,neutral
680518.0,"Iridex Q4 EPS $(0.21) Beats $(0.25) Estimate, Sales $11.47M Beat $10.85M Estimate",2019-03-05 16:08:00-05:00,IRIX,neutral
680519.0,IRIDEX Announces Resolution Of Its Dispute With Quantel Medical,2019-02-12 08:04:00-05:00,IRIX,negative
680520.0,"IRIDEX Sees Q4 Sales $11.0M-$11.3M vs $10.85M Est., FY18 Sales $42.1M-$42.4M vs $42.0M Est.",2019-01-08 16:10:00-05:00,IRIX,neutral
680521.0,"Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018",2018-12-17 11:48:00-05:00,IRIX,negative
680522.0,IRIDEX shares are trading down 6.6% after the company announced the CFO is departing the company.,2018-12-04 17:34:00-05:00,IRIX,positive
680523.0,IRIDEX Reiterates FY18 Guidance; Sees Revenue $41M-$42M vs $42M Est.,2018-12-04 16:27:00-05:00,IRIX,neutral
680524.0,IRIDEX Reports CFO Atabak Mokari Departs The Company,2018-12-04 16:21:00-05:00,IRIX,neutral
680525.0,"IRIDEX Corporation Q3 EPS $(0.26) Beats $(0.28) Estimate, Sales $11.32M Beat $9.69M Estimate",2018-11-01 16:50:00-04:00,IRIX,neutral
680526.0,"Benzinga's Top Upgrades, Downgrades For October 26, 2018",2018-10-26 09:22:00-04:00,IRIX,positive
680527.0,"Stifel Nicolaus Initiates Coverage On Iridex with Buy Rating, Announces $9 Price Target",2018-10-26 08:28:00-04:00,IRIX,neutral
680528.0,48 Biggest Movers From Yesterday,2018-10-17 05:53:00-04:00,IRIX,neutral
680529.0,40 Stocks Moving In Tuesday's Mid-Day Session,2018-10-16 12:46:00-04:00,IRIX,neutral
680530.0,44 Biggest Movers From Friday,2018-09-17 05:10:00-04:00,IRIX,neutral
680531.0,Mid-Afternoon Market Update: U.S. Stocks Turn Lower; Radiant Logistics Shares Rise After Q4 Results,2018-09-14 14:38:00-04:00,IRIX,positive
680532.0,32 Stocks Moving In Friday's Mid-Day Session,2018-09-14 12:31:00-04:00,IRIX,neutral
680533.0,Mid-Day Market Update: Champions Oncology Surges Following Q1 Earnings Beat; IRIDEX Shares Drop,2018-09-14 12:03:00-04:00,IRIX,positive
680534.0,Mid-Morning Market Update: Markets Edge Higher; Dave & Buster's Tops Q2 Views,2018-09-14 10:23:00-04:00,IRIX,positive
680535.0,24 Stocks Moving In Friday's Pre-Market Session,2018-09-14 08:01:00-04:00,IRIX,neutral
680536.0,A Peek Into The Markets: US Stock Futures Gain Ahead Of Economic Data,2018-09-14 07:25:00-04:00,IRIX,positive
680537.0,IRIDEX Prices ~1.67M Share Common Stock Offering At $6/Share,2018-09-14 07:01:00-04:00,IRIX,positive
680538.0,"6 Stocks To Watch For September 14, 2018",2018-09-14 04:31:00-04:00,IRIX,neutral
680539.0,"IRIDEX Announces Common Stock Offering, No Size Disclosed",2018-09-13 16:01:00-04:00,IRIX,negative
680540.0,IRIDEX Announces Its TruFocus LIO Laser Accessory Gets FDA Clearance For the U.S. Market,2018-09-06 16:12:00-04:00,IRIX,neutral
680541.0,IRIDEX Sees FY18 Sales Guidance Of $38-$41M vs $40M Est.,2018-08-02 17:17:00-04:00,IRIX,neutral
680542.0,"Iridex Q2 EPS $(0.28) Beats $(0.32) Estimate, Sales $10.304M Beat $9.2M Estimate",2018-08-02 17:16:00-04:00,IRIX,neutral
680543.0,62 Biggest Movers From Friday,2018-07-30 04:16:00-04:00,IRIX,neutral
680544.0,IRIDEX Reaches Milestone Of 1000th Cyclo G6 System Shipped,2018-07-10 08:13:00-04:00,IRIX,positive
680545.0,IRIDEX Reports Approval of CYCLO G6 Glaucoma Laser System in Korea,2018-06-19 08:07:00-04:00,IRIX,positive
680546.0,IRIDEX Sees FY18 EPS $37M-$41M vs $39.7M Est.,2018-05-03 17:25:00-04:00,IRIX,neutral
680547.0,"Iridex Q1 EPS $(0.31) Beats $(0.33) Estimate, Sales $9.51M Beat $8.8M Estimate",2018-05-03 17:24:00-04:00,IRIX,neutral
680548.0,IRIDEX Reports Received CE Mark For Transilluminated Probe,2018-03-20 08:04:00-04:00,IRIX,neutral
680549.0,IRIDEX Sees FY18 Sales $37M-$41M vs $41.57M Est.,2018-03-08 16:11:00-05:00,IRIX,neutral
680550.0,"IRIDEX Reports Q4 EPS $(0.44) vs $(0.27) Est., Sales $10.243M vs $10.22M Est.",2018-03-08 16:10:00-05:00,IRIX,neutral
680551.0,38 Biggest Movers From Yesterday,2018-02-27 04:58:00-05:00,IRIX,neutral
680552.0,"IRIDEX Corp Shares Down 14.9% Following News Of Voluntary Recall Of TruFocus LIO, Sales Guidance: Q4 $10.2M-$10.3M vs $11M Est., FY17 $41.5M-$41.6M vs $42.4M Est.",2018-02-26 15:53:00-05:00,IRIX,positive
680553.0,Mid-Afternoon Market Update: Telaria Falls Following Q4 Results; Achillion Pharmaceuticals Shares Surge,2018-02-26 14:31:00-05:00,IRIX,positive
680554.0,28 Stocks Moving In Monday's Mid-Day Session,2018-02-26 12:25:00-05:00,IRIX,neutral
680555.0,Mid-Day Market Update: Dow Climbs Over 200 Points; NXT-ID Shares Gain Following Agreement with Discovery Financial Services,2018-02-26 12:02:00-05:00,IRIX,positive
680556.0,Mid-Morning Market Update: Markets Open Higher; Dean Foods Earnings Miss Expectations,2018-02-26 10:15:00-05:00,IRIX,negative
680557.0,IRIDEX Shares Up 3% Mon. Afternoon On Extremely Light Volume; 13G Filing From BlueLine Partners Showed New 8.5% Stake,2018-01-22 12:08:00-05:00,IRIX,positive
680558.0,IRIDEX Announces a Patent Infringement Lawsuit Against Quantel,2018-01-09 07:05:00-05:00,IRIX,negative
680559.0,"IRIDEX Shares Down 1.88%; Earlier Co. Reported Prelim. Q4 Sales $11M-$11.1M vs $12.09M Est., FY17 Sales $42.3M-$42.4M vs $43.44M Est.",2018-01-08 10:57:00-05:00,IRIX,positive
680560.0,"IRIDEX Reports Q3 EPS $(0.27) vs $(0.22) ESt., Sales $10.9M vs $10.04M Est., Reiterates Previously Issued Guidance",2017-11-02 17:17:00-04:00,IRIX,neutral
680561.0,"IRIDEX Reports Q2 EPS $(0.24) vs $(0.12) Est., Sales $10M vs $11.3M Est.",2017-08-03 17:47:00-04:00,IRIX,neutral
680562.0,"IRIDEX Reports Q1 EPS $(0.16) vs $(0.12) Est., Sales $10.483M vs $11.52M Est.",2017-05-03 17:59:00-04:00,IRIX,neutral
680563.0,IRIDEX Sees FY17 Sales $48M-$52M vs $52.8M Est.,2017-03-08 16:04:00-05:00,IRIX,neutral
680564.0,"IRIDEX Reports Q4 EPS $(1.04) vs $0.04 in Same Qtr. Last Year, Sales $12.53M, Inline",2017-03-08 16:04:00-05:00,IRIX,neutral
680565.0,Guidance Monday: 5 Companies Issue Preliminary Guidance,2017-01-09 10:21:00-05:00,IRIX,neutral
680566.0,Iridex Sees FY2016 Sales $46.0M-46.10M vs $46.08M Est,2017-01-09 06:21:00-05:00,IRIX,neutral
680567.0,Iridex Sees Q4 Sales $12.40M-12.50M vs $12.60M Est,2017-01-09 06:20:00-05:00,IRIX,neutral
680568.0,"Roth Capital Initiates Coverage On Iridex at Buy, Announces $20.00 Target",2016-12-21 06:23:00-05:00,IRIX,neutral
680569.0,IRIDEX Prices 1.15M Offering At $14/Share,2016-12-09 08:46:00-05:00,IRIX,neutral
680570.0,IRIDEX Corporation Announces Proposed Public Offering of Common Stock,2016-12-08 16:32:00-05:00,IRIX,neutral
680571.0,"IRIDEX Reports Q3 Loss/Share $0.07 vs Est Loss/Share $0.03, Rev $9.8M vs $11.2M Est",2016-11-03 17:51:00-04:00,IRIX,neutral
680572.0,"UPDATE: IRIDEX New Q3 Revenue Guidance $9.6-$9.7M Down From Prior Guidance Of $11-$11.3M, Cites Disappointing Sales of Certain Retina Products",2016-10-11 16:08:00-04:00,IRIX,negative
680573.0,IRIDEX Reports Prelim Q3 Revenues Of $9.6-$9.7M vs $11.2M Est,2016-10-11 16:06:00-04:00,IRIX,neutral
680574.0,IRIDEX Says Data Shows Long Term Efficacy For Patients Treated with MicroPulse P3,2016-09-07 06:32:00-04:00,IRIX,neutral
680575.0,Mid-Morning Market Update: Markets Open Lower; J C Penney Posts Narrower Q2 Loss,2016-08-12 10:04:00-04:00,IRIX,negative
680576.0,Iridex Selling Stockholders Offering Up to 2.1M Shares of Common Stock; Iridex Won't Receive any of Proceeds from Sale of Common Stock By Selling Stockholders,2016-08-12 06:17:00-04:00,IRIX,positive
680577.0,"Iridex Reports Q2 EPS $(0.03) vs. Est. $0.01, Rev. $11.9M vs. Est. $11.9M",2016-08-04 17:46:00-04:00,IRIX,neutral
680578.0,IRIDEX Announces Atabak Mokari New CFO,2016-07-11 06:34:00-04:00,IRIX,neutral
680579.0,"IRIDEX Reports Q1 EPS $0.01 vs. Est. $0.04, Rev. $11.9M vs. Est. $11.88M",2016-05-05 17:35:00-04:00,IRIX,neutral
680580.0,IRIDEX Reports Gained Patent Approvals Covering TxCell-Guided MicroPulse Laser Therapy,2016-03-22 16:08:00-04:00,IRIX,positive
680581.0,"IRIDEX Reports Q4 EPS $0.04 vs. Prior Year Quarter $0.86, Rev. $12.1M vs. Prior Year Quarter $11.8M",2016-03-03 16:07:00-05:00,IRIX,neutral
680582.0,IRIDEX Announces Receiving CE Mark for Cyclo G6 Laser System,2016-02-16 06:36:00-05:00,IRIX,neutral
680583.0,"Singular Research Initiates Coverage on Iridex at Buy, Announces $11.50 PT",2016-01-26 14:03:00-05:00,IRIX,neutral
680584.0,Iridex Sees FY2015 Sales $41.50M-41.80M,2016-01-11 06:34:00-05:00,IRIX,neutral
680585.0,Iridex Sees Q4 Sales $11.50M-11.90M,2016-01-11 06:31:00-05:00,IRIX,neutral
680586.0,"IRIDEX Reports Q2 Loss $0.07, Sales $9.03M; Sees Q3 Rev $9.7M-$10M",2015-08-06 18:19:00-04:00,IRIX,negative
680587.0,IRIDEX CFO James H Mackaness To Resign,2015-08-04 16:58:00-04:00,IRIX,negative
680588.0,IRIDEX Cuts Q2 Sales Guidance from $10.7M-$11.1M Previously to ~$9M-$9.1M,2015-07-16 06:33:00-04:00,IRIX,negative
680589.0,Top 4 Small-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest ROA,2015-04-22 04:45:00-04:00,IRIX,positive
680590.0,IRIDEX Awarded Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries,2015-03-30 06:33:00-04:00,IRIX,positive
680591.0,"IRIDEX Corp Reports Q4 EPS $0.86, Sales $11.8M, No Estimates Available",2015-03-05 16:08:00-05:00,IRIX,negative
680592.0,"IRIDEX to Debut Cyclo G6 Glaucoma Laser Platform, Present New Clinical Data at AGS Annual Meeting",2015-02-23 06:32:00-05:00,IRIX,neutral
680593.0,US Stock Futures Rise Ahead Of Economic Data,2015-02-02 07:01:00-05:00,IRIX,neutral
680594.0,IRIDEX Annojunces FDA Clearance for Cyclo G6 Laser System for Treatment of Multiple Stages of Glaucoma,2015-02-02 06:32:00-05:00,IRIX,neutral
680595.0,Iridex Sees FY2015 Sales $48.0M-51.0M,2015-01-12 06:34:00-05:00,IRIX,neutral
680596.0,Iridex Sees Q4 Sales $10.90M-11.20M,2015-01-12 06:33:00-05:00,IRIX,neutral
680597.0,IRIDEX Secures Large Ophthalmology Laser Equipment Tender To Supply Rural Chinese Regions,2014-12-02 06:33:00-05:00,IRIX,positive
680598.0,IRIDEX Corporation Reports Q3 EPS of $0.05 vs $0.02 Est; Revenue of $10.10M,2014-10-30 16:10:00-04:00,IRIX,neutral
680599.0,IRIDEX Expands Retinal Portfolio,2014-10-14 06:46:00-04:00,IRIX,positive
680600.0,"IRIDEX Reports Q2 Revenue $10.6M, EPS $0.03",2014-07-31 17:18:00-04:00,IRIX,neutral
680601.0,"US Stock Futures Edge Higher Ahead Of Earnings, Economic Data",2014-05-22 07:20:00-04:00,IRIX,neutral
680602.0,"IRIDEX Multi-Center Study Data Demonstrates Safety, Durability of Proprietary MicroPulse Technology for Treatment of Glaucoma ",2014-05-22 06:44:00-04:00,IRIX,positive
680603.0,IRIDEX Corporation Sees Q2 Sales $10.30M-10.60M,2014-05-01 16:53:00-04:00,IRIX,neutral
680604.0,IRIDEX Corporation Reports Q1 EPS of $0.05 vs $0.06 Est; Revenue of $10.30M,2014-05-01 16:52:00-04:00,IRIX,neutral
680605.0,"IRIDEX Corporation Reports Q4 EPS of $0.04, Inline; Revenue of $10.60M",2014-02-27 16:16:00-05:00,IRIX,neutral
680606.0,Iridex Sees Q4 Revenue of Approximately $10.6M ,2014-01-28 06:43:00-05:00,IRIX,neutral
680607.0,IRIDEX Corporation Sees Q4 Sales $10.20M-10.50M,2013-10-31 16:35:00-04:00,IRIX,neutral
680608.0,IRIDEX Corporation Reports Q3 EPS of $0.05 vs $0.04 Est; Revenue of $9.53M,2013-10-31 16:35:00-04:00,IRIX,neutral
680609.0,IRIDEX Announces Automatic Conversion of Series A Preferred Stock Into Common Stock,2013-06-11 16:07:00-04:00,IRIX,neutral
680610.0,IRIDEX Receives Final $510K Payment from Sale of Aesthetic Business Unit ,2013-05-16 06:19:00-04:00,IRIX,neutral
680611.0,IRIDEX Corporation Sees Q1 Sales $8.90M-9.20M,2013-05-02 16:41:00-04:00,IRIX,neutral
680612.0,IRIDEX Corporation Reports Q1 EPS of $0.09 vs $0.03 Est; Revenue of $8.94M,2013-05-02 16:25:00-04:00,IRIX,neutral
680613.0,A Peek Into The Market Before The Trading Starts,2013-04-02 07:09:00-04:00,IRIX,neutral
680614.0,IRIDEX Enters Global Distribution and Supply Agreement with Peregrine Surgical,2013-04-02 06:49:00-04:00,IRIX,positive
680615.0,Iridex Reports New $3M Buyback Plan,2013-02-28 16:40:00-05:00,IRIX,neutral
680616.0,IRIDEX Corporation Reports Q4 EPS of $0.03 vs $0.02 Est; Revenue of $9.23M,2013-02-28 16:40:00-05:00,IRIX,neutral
680617.0,A Peek Into The Market Before The Trading Starts,2012-12-14 07:22:00-05:00,IRIX,neutral
680618.0,IRIDEX Announces Results of Tender Offer ,2012-12-14 06:32:00-05:00,IRIX,neutral
680619.0,A Peek Into The Market Before The Trading Starts,2012-11-09 07:11:00-05:00,IRIX,neutral
680620.0,"IRIDEX, QUANTEL in Global Licensing Agreement",2012-11-09 06:36:00-05:00,IRIX,positive
680621.0,IRIDEX to Commence Tender Offer for up to 487.5K Shares of Common Stock at $4.10/Share ,2012-11-07 07:23:00-05:00,IRIX,positive
680622.0,IRIDEX Appoints Chairman William M. Moore as Interim President & CEO ,2012-08-29 06:17:00-04:00,IRIX,neutral
680623.0,UPDATE: Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit for $5.1M,2012-01-03 08:47:00-05:00,IRIX,neutral
680624.0,A Peek Into The Market Before The Trading Starts,2012-01-03 07:33:00-05:00,IRIX,neutral
680625.0,Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit for $5.1M,2012-01-03 06:56:00-05:00,IRIX,neutral
680626.0,UK's National Health System Rejects Drug Therapy for Diabetic Macular Edema; Ruling Advances Opportunity for IRIDEX' Tissue Sparing MicroPulse ™ Laser Therapy ,2011-12-13 06:52:00-05:00,IRIX,negative
680627.0,IRIDEX Signs License and Distribution Agreement with Leader in Eye Care  ,2011-11-15 08:00:00-05:00,IRIX,positive
680628.0,"End-of-Day Market Summary for October 10, 2011",2011-10-10 16:15:00-04:00,IRIX,neutral
680629.0,"IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO ",2011-10-10 12:00:00-04:00,IRIX,neutral
680630.0,A Peek Into The Market Before The Trading Starts,2011-09-20 07:24:00-04:00,IRIX,neutral
680631.0,IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics  ,2011-09-20 06:43:00-04:00,IRIX,positive
680632.0,IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery (IRIX),2011-05-02 07:44:00-04:00,IRIX,positive
680633.0,IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter ,2011-03-03 16:18:00-05:00,IRIX,positive
680634.0,IRIDEX Reports Improved Third Quarter 2010 Financial Results: EPS of $0.09,2010-11-04 16:56:00-04:00,IRIX,positive
